Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 153, Issue , 2017, Pages 174-182

  Li, Jing ^a   Zhou, Yu ^a   Zhang, Wei ^b   Bao, Cuiyu ^a   Xie, Zhigang ^b  

^a HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

Author keywords

Apoptosis; Cardiomyocytes; Curcumin; Oxidative stress

Indexed keywords

CELL DEATH; CELL MEMBRANES; NANOPARTICLES; OXIDATIVE STRESS; PALMITIC ACID; PIGMENTS;

CARDIOMYOCYTES; CURCUMIN; ENDOPLASMIC RETICULUM STRESS; LIPID PEROXIDATION; PROTECTIVE EFFECTS; PROTEIN SIGNALING; REACTIVE OXYGEN SPECIES; SIGNALING PATHWAYS;

STRESS RELIEF;

CURCUMIN; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MALONALDEHYDE; NANOPARTICLE; PALMITIC ACID; PEPTIDES AND PROTEINS; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P22PHOX; PROTEIN P47PHOX; PROTEIN P67PHOX; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; PALMITIC ACID DERIVATIVE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG RELEASE; EMBRYO; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; METABOLISM;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CURCUMIN; MYOCYTES, CARDIAC; NANOPARTICLES; OXIDATIVE STRESS; PALMITATES; RATS;

EID: 85013382529     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2017.02.023     Document Type: Article

References (49)

1. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29 (2011), 415–445.
2. Mathieu, P., Lemieux, I., Despres, J.P., Obesity inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87 (2010), 407–416.
3. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420 (2002), 860–867.
4. Ndisang, J.F., Vannacci, A., Rastogi, S., Oxidative stress and inflammation in obesity, diabetes, hypertension, and related cardiometabolic complications. Oxid. Med. Cell. Longev., 2014, 2014, 506948.
5. Boden, G., Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 18 (2011), 139–143.
6. Hammer, S., Snel, M., Lamb, H.J., Jazet, I.M., van der Meer, R.W., Pijl, H., Meinders, E.A., Romijn, J.A., de Roos, A., Smit, J.W., Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol. 52 (2008), 1006–1012.
7. Viljanen, A.P., Karmi, A., Borra, R., Parkka, J.P., Lepomaki, V., Parkkola, R., Lautamaki, R., Jarvisalo, M., Taittonen, M., Ronnemaa, T., Iozzo, P., Knuuti, J., Nuutila, P., Raitakari, O.T., Effect of caloric restriction on myocardial fatty acid uptake left ventricular mass, and cardiac work in obese adults. Am. J. Cardiol. 103 (2009), 1721–1726.
8. Zhou, Y.T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., Unger, R.H., Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 1784–1789.
9. Hickson-Bick, D.L., Buja, L.M., McMillin, J.B., Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J. Mol. Cell. Cardiol. 32 (2000), 511–519.
10. Lin, N., Chen, H., Zhang, H., Wan, X., Su, Q., Mitochondrial reactive oxygen species (ROS) inhibition ameliorates palmitate-induced INS-1 beta cell death. Endocrine 42 (2012), 107–117.
11. Nicoletti, N.F., Rodrigues-Junior, V., Santos, A.A. Jr., Leite, C.E., Dias, A.C., Batista, E.L. Jr., Basso, L.A., Campos, M.M., Santos, D.S., Souto, A.A., Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation. J. Nat. Prod. 77 (2014), 2190–2195.
12. Wold, L.E., Ceylan-Isik, A.F., Ren, J., Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol. Sin. 26 (2005), 908–917.
13. Syed, I., Kyathanahalli, C.N., Jayaram, B., Govind, S., Rhodes, C.J., Kowluru, R.A., Kowluru, A., Increased phagocyte-like NADPH oxidase and ROS generation in type 2 diabetic ZDF rat and human islets: role of Rac1-JNK1/2 signaling pathway in mitochondrial dysregulation in the diabetic islet. Diabetes 60 (2011), 2843–2852.
14. Cave, A.C., Brewer, A.C., Narayanapanicker, A., Ray, R., Grieve, D.J., Walker, S., Shah, A.M., NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8 (2006), 691–728.
15. Gao, L., Mann, G.E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 82 (2009), 9–20.
16. Teixeira, C.C.C., Mendonça, L.M., Bergamaschi, M.M., Queiroz, R.H.C., Souza, G.E.P., Antunes, L.M.G., Freitas, L.A.P., Microparticles containing curcumin solid dispersion: stability, bioavailability and anti-inflammatory activity. AAPS Pharm. Sci. Technol. 17 (2016), 252–261.
17. Nemmar, A., Subramaniyan, D., Ali, B.H., Protective effect of curcumin on pulmonary and cardiovascular effects induced by repeated exposure to diesel exhaust particles in mice. PLoS One, 7, 2012, e39554.
18. Zhuang, X.D., Liao, L.Z., Dong, X.B., Hu, X., Guo, Y., Du, Z.M., Liao, X.X., Wang, L.C., Design synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases. Drug Des. Dev. Ther. 10 (2016), 129–139.
19. Betbeder, D., Lipka, E., Howsam, M., Carpentier, R., Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact onantioxidant and antinitrosant properties. Int. J. Nanomed. 10 (2015), 5355–5366.
20. Khumsupan, P., Ramirez, R., Khumsupan, D., Narayanaswami, V., Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid. Biochim. Biophys. Acta 1808 (2011), 352–359.
21. Zingg, J.M., Hasan, S.T., Meydani, M., Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors 39 (2013), 101–121.
22. Izem-Meziane, M., Djerdjouri, B., Rimbaud, S., Caffin, F., Fortin, D., Garnier, A., Veksler, V., Joubert, F., Ventura-Clapier, R., Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin. Am. J. Physiol. Heart Circ. Physiol. 302 (2012), 665–674.
23. Pan, Y., Wang, Y., Zhao, Y., Peng, K., Li, W., Zhang, J., Zhou, S., Liu, Q., Li, X., Cai, L., Liang, G., Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes 63 (2014), 3497–3511.
24. Yu, W., Wu, J., Cai, F., Xiang, J., Zha, W., Fan, D., Guo, S., Ming, Z., Liu, C., Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One, 7, 2012, e52013.
25. Zheng, M., Liu, S., Guan, X., Xie, Z., One-step synthesis of nanoscale zeolitic imidazolate frameworks with high curcumin loading for treatment of cervical cancer. ACS Appl. Mater. Interfaces 7 (2015), 22181–22187.
26. Li, M., Gao, M., Fu, Y., Chen, C., Meng, X., Fan, A., Kong, D., Wang, Z., Zhao, Y., Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery. Colloids Surf. B Biointerfaces 140 (2016), 11–18.
27. Kesharwani, P., Banerjee, S., Padhye, S., Sarkar, F.H., Iyer, A.K., Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Colloids Surf. B Biointerfaces 132 (2015), 138–145.
28. Sun, T., Qi, J., Zheng, M., Xie, Z., Wang, Z., Jing, X., Thiadiazole molecules and poly(ethylene glycol)-block-polylactide self-assembled nanoparticles as effective photothermal agents. Colloids Surf. B Biointerfaces 136 (2015), 201–206.
29. Zhang, Y., Babcock, S.A., Hu, N., Maris, J.R., Wang, H., Ren, J., Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function. BMC Med., 10, 2012, 40.
30. Van Gaal, L.F., Mertens, I.L., De Block, C.E., Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006), 875–880.
31. Wende, A.R., Symons, J.D., Abel, E.D., Mechanisms of lipotoxicity in the cardiovascular system. Curr. Hypertens. Rep. 14 (2012), 517–531.
32. Liu, Y.S., Huang, Z.W., Wang, L., Liu, X.X., Wang, Y.M., Zhang, Y., Zhang, M., Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats. J. Pharmacol. Sci. 127 (2015), 260–274.
33. Morimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., Komeda, M., Fujita, M., Shimatsu, A., Kita, T., Hasegawa, K., The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J. Clin. Invest. 118 (2008), 868–878.
34. Antrobus, R., Borner, G.H., Improved elution conditions for native co-immunoprecipitation. PLoS One, 6, 2011, e18218.
35. Rana, S., Datta, K., Reddy, T.L., Chatterjee, E., Sen, P., Pal-Bhadra, M., Bhadra, U., Pramanik, A., Pramanik, P., Chawla-Sarkar, M., Sarkar, S., A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect. J. Controlled Release 200 (2015), 167–178.
36. Guo, S., Yao, Q., Ke, Z., Chen, H., Wu, J., Liu, C., Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK. Mol. Cell. Endocrinol. 412 (2015), 85–94.
37. Oelze, M., Daiber, A., Brandes, R.P., Hortmann, M., Wenzel, P., Hink, U., Schulz, E., Mollnau, H., von Sandersleben, A., Kleschyov, A.L., Mulsch, A., Li, H., Forstermann, U., Munzel, T., Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48 (2006), 677–684.
38. Hordijk, P.L., Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. 98 (2006), 453–462.
39. Zhang, J., Gu, J.Y., Chen, Z.S., Xing, K.C., Sun, B., Astragalus polysaccharide suppresses palmitate-induced apoptosis in human cardiac myocytes: the role of Nrf1 and antioxidant response. Int. J. Clin. Exp. Pathol. 8 (2015), 2515–2524.
40. Benbrook, D.M., Long, A., Integration of autophagy proteasomal degradation, unfolded protein response and apoptosis. Exp. Oncol. 34 (2012), 286–297.
41. Patterson, C., Cyr, D., Welcome to the machine: a cardiologist's introduction to protein folding and degradation. Circulation 106 (2002), 2741–2746.
42. Groenendyk, J., Agellon, L.B., Michalak, M., Coping with endoplasmic reticulum stress in the cardiovascular system. Annu. Rev. Physiol. 75 (2013), 49–67.
43. Okada, K., Minamino, T., Tsukamoto, Y., Liao, Y., Tsukamoto, O., Takashima, S., Hirata, A., Fujita, M., Nagamachi, Y., Nakatani, T., Yutani, C., Ozawa, K., Ogawa, S., Tomoike, H., Hori, M., Kitakaze, M., Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110 (2004), 705–712.
44. Szegezdi, E., Duffy, A., O'Mahoney, M.E., Logue, S.E., Mylotte, L.A., O'Brien, T., Samali, A., ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem. Biophys. Res. Commun. 349 (2006), 1406–1411.
45. Minamino, T., Komuro, I., Kitakaze, M., Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. Circ. Res. 107 (2010), 1071–1082.
46. Popov, D., Endoplasmic reticulum stress and the on site function of resident PTP1B. Biochem. Biophys. Res. Commun. 422 (2012), 535–538.
47. Liu, X.A., Song, J., Jiang, Q., Wang, Q., Tian, Q., Wang, J.Z., Expression of the hyperphosphorylated tau attenuates ER stress-induced apoptosis with upregulation of unfolded protein response. Apoptosis 17 (2012), 1039–1049.
48. Palomer, X., Capdevila-Busquets, E., Garreta, G., Davidson, M.M., Vazquez-Carrera, M., PPARalpha attenuates palmitate-induced endoplasmic reticulum stress in human cardiac cells by enhancing AMPK activity. Clin. Investig. Arterioscler. 26 (2014), 255–267.
49. Zhao, Q., Hu, X., Shao, L., Wu, G., Du, J., Xia, J., LipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in rats. Heart Vessels 29 (2014), 667–678.